0ABG Stock Overview
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in Sweden, the United Kingdom, Rest of Europe, North America, Asia, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Swedencare AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 44.46 |
| 52 Week High | SEK 68.48 |
| 52 Week Low | SEK 40.00 |
| Beta | 0.89 |
| 11 Month Change | 9.29% |
| 3 Month Change | 5.81% |
| 1 Year Change | -19.28% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -48.76% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0ABG | GB Pharmaceuticals | GB Market | |
|---|---|---|---|
| 7D | -0.9% | -2.2% | -0.3% |
| 1Y | -19.3% | -3.2% | 6.1% |
Return vs Industry: 0ABG underperformed the UK Pharmaceuticals industry which returned -4% over the past year.
Return vs Market: 0ABG underperformed the UK Market which returned 5.6% over the past year.
Price Volatility
| 0ABG volatility | |
|---|---|
| 0ABG Average Weekly Movement | 6.4% |
| Pharmaceuticals Industry Average Movement | 6.5% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0ABG has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: 0ABG's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 570 | Hakan Lagerberg | www.swedencare.com |
Swedencare AB (publ), together with its subsidiaries, develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in Sweden, the United Kingdom, Rest of Europe, North America, Asia, and internationally. The company offers animal nutritional supplements, treats, and grooming products under the Healthy Breeds name; pet supplements and topical products for various therapeutic areas, such as orthopedics, behavior, dermatology, odontostomatology, algology, gastroenterology, urology, nephrology, and ophthalmology under the Innovet name; and support and solutions for the veterinary community under the Stratford Animal Health name. It also provides pet health supplements under the NaturVet, VETCLASSICS, and NutriScience name; pet supplements, vitamins, dental care, ear cleaners, pilling agents, and topicals under the Pet MD name; and vet-formulated pet care products under the VetWELL name.
Swedencare AB (publ) Fundamentals Summary
| 0ABG fundamental statistics | |
|---|---|
| Market cap | SEK 7.11b |
| Earnings (TTM) | SEK 62.10m |
| Revenue (TTM) | SEK 2.50b |
114.5x
P/E Ratio2.8x
P/S RatioIs 0ABG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0ABG income statement (TTM) | |
|---|---|
| Revenue | SEK 2.50b |
| Cost of Revenue | SEK 1.06b |
| Gross Profit | SEK 1.45b |
| Other Expenses | SEK 1.39b |
| Earnings | SEK 62.10m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 13, 2025
| Earnings per share (EPS) | 0.39 |
| Gross Margin | 57.86% |
| Net Profit Margin | 2.48% |
| Debt/Equity Ratio | 18.0% |
How did 0ABG perform over the long term?
See historical performance and comparison